Clinical trial
Study in Letrozole Combined With Metronomic Oral Cyclophosphamide in Elderly Metastasis Breast Cancer Patients
NCT02583828 is registered in ClinicalTrials.gov with Capital Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study in Letrozole Combined With Metronomic Oral Cyclophosphamide in Elderly Metastasis Breast Cancer Patients
- Lead sponsor
- Capital Medical University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 30, 2015
- Completion date
- December 31, 2021
- Enrollment
- 200 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.